Also subject to the restriction is a phase 2 trial in myeloid malignancies and ... through the industry pipeline directed at CD47, a protein expressed on malignant cells that has long been ...
Learn how vitamin D, magnesium, and fish oil can improve asthma outcomes. Discover evidence-based strategies for co-treating ...
Nearly everyone will need to know how to get rid of gas at some point in their lifetime. Over-the-counter medications can be very effective. However, there are natural remedies that relieve gas (often ...
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...
Scientists have discovered a protein that enables bacteria to shut down into dormant spores under extreme conditions. The ...
On the other hand, the antibody-drug conjugate (ADC) DB-1305/BNT325, targeting TROP-2, led to objective responses in 41.4%, disease control in 82%, and a median PFS of 7.3 months in a small ...
A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...
Recent work in The EMBO Journal describes a new hybrid post-translational modification of proteins, composed of a poly-ubiquitin chain that is attached to a target protein via a mono-ADP-ribose (MAR) ...
A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.
A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.
1 and 2). The swelling predominated in the region of the posterior third of the gland, and, when the swelling was severe, the ear lobes were hidden when the patient was viewed from the front.
AstraZeneca and partner Daiichi Sankyo have their first phase 3 data for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) – in lung cancer – in one of the most ...